Contribute Try STAT+ Today

If health tech challenges were mountains, patient medical records would be a kind of Everest, with the gear of tech giants and digital health startups alike lying abandoned along its precipitous path. Now, a new contender is making the climb.

The company, called Seqster (pronounced “seek-ster”), on Thursday raised its first public funding, a $12 million Series A round led by Omni Health Holdings, with additional investment from Takeda Digital Ventures and Anne Wojcicki, founder and chief executive officer of 23andMe. The data-syncing platform lets patients combine health information from electronic health records, wearables, DNA sequencing platforms, and other sources.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.